Bruce G Haffty Selected Research

Squamous Cell Neoplasms (Squamous Cell Cancer)

4/2005	beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
2/2005	Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
1/2005	Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce G Haffty Research Topics

Disease

131	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2002
79	Neoplasms (Cancer) 07/2023 - 12/2002
22	Neoplasm Metastasis (Metastasis) 07/2023 - 03/2002
15	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 12/2002
9	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2003
6	Laryngeal Neoplasms (Laryngeal Cancer) 06/2013 - 01/2004
4	Triple Negative Breast Neoplasms 03/2024 - 06/2010
4	Carcinoma (Carcinomatosis) 01/2018 - 09/2005
4	Necrosis 08/2017 - 12/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2016 - 07/2006
3	Unilateral Breast Neoplasms 01/2021 - 01/2014
3	Glioma (Gliomas) 04/2019 - 05/2015
3	Cardiotoxicity 01/2019 - 01/2014
3	Lung Neoplasms (Lung Cancer) 09/2016 - 04/2013
3	Ductal Carcinoma 06/2015 - 12/2009
3	Colorectal Neoplasms (Colorectal Cancer) 06/2014 - 02/2010
3	Seroma 05/2014 - 11/2010
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2005 - 01/2005
2	Skin Neoplasms (Skin Cancer) 01/2023 - 09/2015
2	COVID-19 01/2021 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 09/2009
2	Pain (Aches) 01/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 11/2017
2	Cicatrix (Scar) 01/2020 - 06/2017
2	Carcinogenesis 01/2020 - 04/2005
2	Fatigue 01/2020 - 09/2011
2	Infections 06/2017 - 09/2009
2	Heart Diseases (Heart Disease) 01/2015 - 09/2011
2	Brain Neoplasms (Brain Tumor) 06/2014 - 04/2011
2	Rectal Neoplasms (Rectal Cancer) 03/2014 - 01/2012
1	Breast Cancer 3 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Severe Acute Respiratory Syndrome 07/2021
1	Lymphoma (Lymphomas) 01/2021
1	Leukemia 01/2021
1	Lymphedema (Milroy Disease) 01/2020

Drug/Important Bio-Agent (IBA)

21	Estrogen ReceptorsIBA 01/2018 - 05/2003
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2005
13	Progesterone Receptors (Progesterone Receptor)IBA 07/2023 - 05/2003
12	Hormones (Hormone)IBA 03/2017 - 10/2003
11	ParaffinIBA 02/2012 - 03/2003
7	Estrogens (Estrogen)FDA Link 07/2023 - 07/2008
6	Biomarkers (Surrogate Marker)IBA 01/2014 - 05/2003
5	human ERBB2 proteinIBA 01/2019 - 06/2010
5	Dihydrotachysterol (AT 10)IBA 06/2010 - 07/2003
5	Cyclin D1IBA 07/2009 - 10/2003
4	EnzymesIBA 12/2022 - 03/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2014 - 01/2005
3	Protons (Proton)IBA 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2019 - 06/2010
3	Indicators and Reagents (Reagents)IBA 06/2014 - 02/2010
3	GoldIBA 05/2014 - 11/2010
3	DNA (Deoxyribonucleic Acid)IBA 06/2010 - 02/2006
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2008 - 03/2004
3	Hemoglobins (Hemoglobin)IBA 01/2005 - 03/2004
2	Ligases (Synthetase)IBA 01/2023 - 09/2016
2	UbiquitinIBA 01/2023 - 09/2016
2	Monomeric GTP-Binding ProteinsIBA 12/2022 - 01/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 11/2017
2	Glutamic Acid (Glutamate)FDA Link 04/2019 - 04/2011
2	Riluzole FDA LinkGeneric 04/2019 - 04/2011
2	TIC10 compoundIBA 01/2019 - 08/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 06/2014
2	Metformin (Glucophage)FDA LinkGeneric 03/2015 - 01/2013
2	Fulvestrant (Faslodex)FDA Link 08/2014 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2014 - 01/2005
2	Tamoxifen FDA LinkGeneric 09/2013 - 01/2005
2	Carrier Proteins (Binding Protein)IBA 08/2012 - 06/2011
2	AntibodiesIBA 12/2011 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 02/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2010 - 03/2006
2	beta CateninIBA 09/2009 - 04/2005
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2006 - 01/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2003 - 01/2002
1	Immune Checkpoint InhibitorsIBA 01/2023
1	GTP Phosphohydrolases (GTPases)IBA 12/2022
1	Lactate Dehydrogenase 5IBA 12/2022
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 12/2022
1	Viral RNAIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Serine (L-Serine)FDA Link 01/2020
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2020

Therapy/Procedure

102	Radiotherapy 03/2024 - 03/2002
49	Segmental Mastectomy (Lumpectomy) 07/2023 - 04/2002
41	Therapeutics 10/2023 - 03/2002
27	Mastectomy (Mammectomy) 01/2023 - 03/2002
14	Drug Therapy (Chemotherapy) 01/2019 - 09/2005
10	Brachytherapy 07/2023 - 12/2008
6	Neoadjuvant Therapy 01/2019 - 10/2009
6	Adjuvant Radiotherapy 01/2013 - 10/2006
3	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 10/2013
2	Proton Therapy 01/2023 - 10/2021
2	Salvage Therapy 06/2014 - 03/2004
2	Image-Guided Radiotherapy 04/2013 - 11/2007
2	Conservative Treatment 12/2006 - 04/2004
2	Duration of Therapy 11/2004 - 03/2004
1	Immunotherapy 01/2023
1	Re-Irradiation 01/2022
1	Treatment Delay 01/2021